This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (19)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Alert me on articles by topic

Snehal G. Patel, MD; Daniel G. Coit, MD; Ashok R. Shaha, MD; Mary Sue Brady, MD; Jay O. Boyle, MD; Bhuvanesh Singh, MD; Jatin P. Shah, MD; Dennis H. Kraus, MD

Arch Otolaryngol Head Neck Surg. 2002;128:285-291.

Objective  To report the results of sentinel lymph node biopsy (SLNB) for cutaneous head and neck melanomas (CMHNs).

Design  Consecutive series followed for a median of 20 months.

Setting  Tertiary cancer care center.

Patients  Fifty-six individuals with clinically node-negative CMHN, median Breslow thickness, 2.6 mm (range, 0.2-20.0 mm).

Interventions  Preoperative technetium 99m sulfur colloid lymphoscintigraphy (PLSG) followed within 4 hours by intraoperative handheld gamma probe localization (IHGP). Intraoperative injection of 1% isosulfan blue dye (IBD) was used in 48 patients. Immediate completion nodal dissection was performed for metastatic SLNs on intraoperative frozen section analysis and monitoring for negative SLNs.

Main Outcome Measures  Rate of SLN identification, SLN and non-SLN positivity, same-basin recurrence, and disease-specific and recurrence-free survival.

Results  Combination of IHGP and IBD improved SLN identification to 96% from 93% for IHGP and 73% for IBD alone. Four patients had a positive SLN on frozen section analysis. A negative SLNB correctly predicted regional nodal control in 47 of 48 patients but missed 1 of 5 patients who had regional lymphatic disease. All 4 patients who failed SLNB remain alive and free of recurrent disease. Two-year Kaplan-Meier disease-specific and relapse-free survival was 91% and 88%, respectively. Two-year disease-specific survival was 93% for SLN-negative patients and 50% for SLN-positive patients (P= .20).

Conclusions  Combining PLSG with IHGP and IBD improves the success rate of SLNB. Although SLNB is a reliable indicator of the status of the draining lymphatic basins in CMHN, patients with negative SLNs must be observed for longer periods to understand the true implications of the procedure.

From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.

RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2002;128(3):332-334.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck
Bradford and Levine
JAMA 2007;297:2628-2629.
FULL TEXT  

Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
Leong et al.
Arch Otolaryngol Head Neck Surg 2006;132:370-373.
ABSTRACT | FULL TEXT  

Patterns of Drainage and Recurrence Following Sentinel Lymph Node Biopsy for Cutaneous Melanoma of the Head and Neck
Fincher et al.
Arch Otolaryngol Head Neck Surg 2004;130:844-848.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy for Patients With Cutaneous Desmoplastic Melanoma
Gyorki et al.
Ann. Surg. Oncol. 2003;10:403-407.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy for Head and Neck Melanomas
Chao et al.
Ann. Surg. Oncol. 2003;10:21-26.
ABSTRACT | FULL TEXT  

Reliability of Sentinel Lymph Node Mapping With Biopsy for Head and Neck Cutaneous Melanoma
Schmalbach et al.
Arch Otolaryngol Head Neck Surg 2003;129:61-65.
ABSTRACT | FULL TEXT